Why Dose Adjustment may be needed:
| Medication | Safety in Pregnancy | Teratogenicity | Dose Adjustment Needed | Guideline |
|---|---|---|---|---|
| ‣ | ||||
| Cautious, depends on type | ||||
| Spontaneous abortion, low birth weight, neonatal serotonin syndrome, neonatal behavioural syndrome (withdrawal), possible abnormal neurobehavioural issues beyond neonatal period,and persistent pulmonary hypertension of the newborn | Individualized | |||
| Prefer ‣ in Pregnancy, avoid ‣ | ||||
| ‣ | ||||
| Safe | ||||
| No | ||||
| Yes, often increased, and monitored | ||||
| Test TSH if RF (universal screening not recommended), |
Monitor TSH in pregnancy First trimester: 0.1–2.5 mIU/L; Second trimester: 0.2–3.0 mIU/L; Third trimester: 0.3–3.0 mIU/L. | | ‣ (‣) | Depends on time | May closes ductus arteriosus prematurely | No | Avoid after W30 |
Patients on these medications should be referred for pre-conceptual counseling and medication changes should be made as able. Medication changes may mean decreasing to lowest effective dose or changing to alternate agents.
| Medication | Approach |
|---|---|
| ‣ | STOP |
| ‣ | Switch to ‣ |
| ‣ | ‣ |
| ‣ → ‣, ‣, ‣ | Switch to ‣, ‣ |
<aside> 🌐
